Zinc finger and BTB domain-containing protein 32 is aprotein that in humans is encoded by the 1960 bpZBTB32gene. The 52 kDa protein (487 aa) is a transcriptionalrepressor and the gene is expressed inT andB cells upon activation, but also significantly in testis cells. It is a member of thePoxviruses and Zinc-finger (POZ) andKrüppel (POK) family of proteins,[5][6] and was identified in multiple screens involving either immune cell tumorigenesis or immune cell development.
The protein recruits histone modification enzymes to chromatin to affect gene activation.[7] ZBTB32 recruits corepressors, such asN-CoR andHDACs to its target genes, induces repressive chromatin states and acts cooperatively with other proteins, e.g. withBlimp-1,[7] to suppress the transcription of genes .[7]
It contains a N-terminalBTB/POZ domain (IPR000210) or a SKP1/BTB/POZ domain (IPR011333), and three C-terminalzinc fingers, Znf_C2H2_sf. (IPR036236), Znf_C2H2_type domain (IPR013087), a Znf_RING/FYVE/PHD domain (IPR013083), followed by a putative UBZ4 domain.[8]
Fanconi anemia complementation group C (Fancc)[9][10]
Thioredoxin interacting protein (Txnip), but the interaction might be unspecific; however, Vitamin D3 upregulated protein 1 (VDUP1) seems to interact[11]
Zinc finger and BTB domain-containing protein 16 (Zbtb16)[5]
Zinc-finger elbow-related proline domain protein 2 (Zpo2)[12]
Zbtb32knockout mice show a trend to developtype 1 diabetes, although the difference is not statistically different. Furthermore the Zbtb32 do not show a difference inlymphocyte proliferation, possibly due to compensation from other genes.[15]
ZBTB32 is highly expressed in spermatogonial stem cells, in hematopoietic stem and progenitor cells, indiffuse large B-cell lymphoma (DLBCL) and appears to suppress the immune system by silencing theCIITA gene.[16]
The transcription factor geneGATA3 is altered in mammary tumors. Down-regulation ofGATA3 expression and activity by the Zinc-finger elbow-related proline domain protein 2 (Zpo2), whereas Zbtb32 facilitates Zpo2 targeting to theGATA3 promoter, results in the development of aggressive breast cancers.[12]
A DNA methylation correlation network was built based on the methylation correlation between differentially methylated genes. A survival analysis of candidate biomarkers was performed. One of eight biomarkers and hub genes identifiedin colon cancer isZBTB32.[17]
The expression of Zbtb32 is upregulated after exposure tocisplatin.[18]
^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
^abHoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A, Licht JD (December 1999). "A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF".Blood.94 (11):3737–47.doi:10.1182/blood.V94.11.3737.PMID10572087.
^Rizzo AA, Salerno PE, Bezsonova I, Korzhnev DM (September 2014). "NMR structure of the human Rad18 zinc finger in complex with ubiquitin defines a class of UBZ domains in proteins linked to the DNA damage response".Biochemistry.53 (37):5895–906.doi:10.1021/bi500823h.PMID25162118.
^Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A, Licht JD (December 1999). "A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF".Blood.94 (11):3737–47.doi:10.1182/blood.V94.11.3737.PMID10572087.
^Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, Gross HJ, Joenje H, Hoatlin ME, Mathew CG, Huber PA (October 2003). "Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport".Experimental Cell Research.289 (2):211–21.doi:10.1016/s0014-4827(03)00261-1.PMID14499622.
^Beaulieu AM, Madera S, Sun JC (2015). "Molecular Programming of Immunological Memory in Natural Killer Cells".Crossroads Between Innate and Adaptive Immunity V. Advances in Experimental Medicine and Biology. Vol. 850. pp. 81–91.doi:10.1007/978-3-319-15774-0_7.ISBN978-3-319-15773-3.PMID26324348.
Lin W, Lai CH, Tang CJ, Huang CJ, Tang TK (November 1999). "Identification and gene structure of a novel human PLZF-related transcription factor gene, TZFP".Biochemical and Biophysical Research Communications.264 (3):789–95.Bibcode:1999BBRC..264..789L.doi:10.1006/bbrc.1999.1594.PMID10544010.
Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, Gross HJ, Joenje H, Hoatlin ME, Mathew CG, Huber PA (October 2003). "Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport".Experimental Cell Research.289 (2):211–21.doi:10.1016/S0014-4827(03)00261-1.PMID14499622.
Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J,Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (October 2005). "Towards a proteome-scale map of the human protein–protein interaction network".Nature.437 (7062):1173–8.Bibcode:2005Natur.437.1173R.doi:10.1038/nature04209.PMID16189514.S2CID4427026.
